|
Connecting Specialists Worldwide
SENOLOGY
GROUP on LiINKEDIN now has more
than 1000 MEMBERS! JOIN US!
Join us on
LinkedIn, ResearchGate,
Doctorsbook,
Twitter, Facebook,
Google
Groups, YouTube, SlideShare,
Flickr, and
share informations and opinions. Check out Senology.org
Newspaper and follow our RSS
feeds for real-time updates 
Literature Selection
-
Kremer ME et
al.: "Neglecting to screen women between the ages of 40 and
49 years with mammography: what is the impact on breast cancer
diagnosis?", AJR
Am J Roentgenol. 2012 May;198(5):1218-22
-
Kalager M et
al.: "Overdiagnosis of invasive breast cancer due to
mammography screening: results from the Norwegian screening
program", Ann
Intern Med. 2012 Apr 3;156(7):491-9
-
Berg WA et
al.: "Detection of breast cancer with addition of annual
screening ultrasound or a single screening MRI to mammography in
women with elevated breast cancer risk", JAMA.
2012 Apr 4;307(13):1394-404
-
Vincent-Salomon
A et al.: "High Ki67 expression is a risk marker of invasive
relapse for classical lobular carcinoma in situ patients", Breast.
2012 Apr 22. [Epub ahead of print]
-
Le Ray I et
al.: "Neoadjuvant therapy for breast cancer has no benefits
on overall survival or on the mastectomy rate in routine clinical
practice. A population-based study with a median follow-up of
11years using propensity score matching", Eur
J Cancer. 2012 Apr 16. [Epub ahead of print]
-
Smith GL et
al.: "Association between treatment with brachytherapy vs
whole-breast irradiation and subsequent mastectomy, complications,
and survival among older women with invasive breast cancer", JAMA.
2012 May 2;307(17):1827-37
-
Chen
WW et al.: "The impact of diabetes mellitus on prognosis of
early breast cancer in Asia", Oncologist.
2012 Apr;17(4):485-91
-
Ottini L et
al.: "Clinical and pathologic characteristics of
BRCA-positive and BRCA-negative male breast cancer patients:
results from a collaborative multicenter study in Italy", Breast
Cancer Res Treat. 2012 Apr 18. [Epub ahead of print]
Discussion
-
"Breast cancer screening with
mammography
"
- Share your opinion
on
LinkedIn®
Focus on - CLEOPATRA trial
Calendar of Events
- 14th
Milan Breast Cancer Conference, June 20-22, 2012, Milan, Italy
- Benign
Breast Diseases, Breast Cancer and Basic Science, June 27-30,
2012, Naoussa,
Macedonia, Greece
- 17th
World Congress on Breast Diseases of the Senologic International
Society, -SIS, October 10-13, 2012, Salvador, Bahia, Brazil
- 8th
Meet the Professor. Advanced International Breast Cancer
Conference (AIBCC), November 15-17, 2012, Padova , Italy
Fragments of History
- William
S Halsted (New York, 1852-1922), "The
results of radical operations
for the cure of carcinoma of the breast", Ann Surg.
July 1907:46(1):1-19":
“The Operation - (...) It must be our endeavor to trace more definitely the routes travelled
in the metastases to bone, particularly to the humerus, for it is
even possible in case of involvement of this bone that
amputation of the shoulder joint plus a proper removal of the
soft parts might eradicate the disease. So, too, it is
conceivable that ultimately, when our knowledge of the
lymphatics traversed in cases of femur involvement becomes
sufficiently exact, amputation at the hip joint may seem
indicated"
Literature Selection
- Smith AJ
et al.: "Risk of cancer in first seven years after
metal-on-metal hip replacement compared with other bearings and
general population: linkage study between the National Joint
Registry of England and Wales and hospital episode statistics",
BMJ.
2012 Apr 3;344:e2383
- Schlumberger
M et al.: "Strategies of radioiodine ablation in patients
with low-risk thyroid cancer", N
Engl J Med. 2012 May 3;366(18):1663-73
- Seghir Z
et al.: "CT screening for lung cancer brings forward early
disease. The randomised Danish Lung Cancer Screening Trial:
status after five annual screening rounds with low-dose CT",
Thorax. 2012 Apr;67(4):296-301
- Ho YF et
al.: "Oral Bisphosphonates and Risk of Esophageal Cancer: A
Dose-Intensity Analysis in a Nationwide Population", Cancer
Epidemiol Biomarkers Prev. 2012 Apr 20. [Epub ahead of
print]
- Broughton
T et al.: "Statin use is associated with a reduced
incidence of colorectal cancer: a colonoscopy-controlled case-
control study", BMC
Gastroenterol. 2012 Apr 24;12(1):36. [Epub ahead of
print]
- Turati F
et al.: "Family history of liver cancer and hepatocellular
carcinoma", Hepatology.
2012 May;55(5):1416-25
- Giannini
E et al.: "Alpha-fetoprotein has no prognostic role in
small hepatocellular carcinoma identified during surveillance in
compensated cirrhosis", Hepatology.
2012 Apr 26 [Epub ahead of print]
- Kang J
et al.: "A DNA Repair Pathway-Focused Score for Prediction
of Outcomes in Ovarian Cancer Treated With Platinum-Based
Chemotherapy", J
Natl Cancer Inst. 2012 Apr 13. [Epub ahead of print]
- Tan HI
et al.: "Long-term survival following partial vs radical
nephrectomy among older patients with early-stage kidney cancer",
JAMA.
2012 Apr 18;307(15):1629-35
- James ND
et al.: "Radiotherapy with or without chemotherapy in
muscle-invasive bladder cancer", N
Engl J Med. 2012 Apr 19;366(16):1477-88
- Leongamornlert
D et al.: "Germline BRCA1 mutations increase prostate
cancer risk", Br
J Cancer. 2012 Apr 19. doi: 10.1038/bjc.2012.146. [Epub
ahead of print]
-
Ahmed HU et
al.: "Focal therapy for localised unifocal and multifocal
prostate cancer: a prospective development study", Lancet
Oncol. 2012 Apr 16. [Epub ahead of print]
Comment
- "Metformin
in the treatment of pancreatic cancer", Donghui
Li, Department of Gastrointestinal Medical Oncology, The
University of Texas MD Anderson Cancer Center, Houston, TX, USA
"Patients
with pancreatic cancer often have a high prevalence (80%) of concurrent
diabetes or impaired glucose tolerance, which are characterized by
peripheral insulin resistance. Accumulating
epidemiological and experimental evidence suggest metformin, the most
commonly used antidiabetic drug, as an antitumor agent. In our retrospective
study of 302 diabetic patients with pancreatic cancer, we observed that
metformin users had 4 months longer overall survival time, 32% reduced risk
of death, and about 2-fold higher 2-year survival rate than the nonmetformin
group. These observations add supporting evidence for the antitumor activity
of metformin. Findings from this retrospective investigation should prompt
future research to test the hypothesis that metformin can be used as a
supplemental therapy in the treatment of pancreatic cancer."
(Comment
on:
Sadeghi
N et al.: "Metformin Use Is Associated with Better Survival of Diabetic
Patients with Pancreatic Cancer", Clin
Cancer Res. 2012 Mar 31. [Epub ahead of print])
Literature Selection
Senology.org
collaborates with TalkAboutHealth.com
- "Cancer questions, answers, and support". Follow the Expert
Q&A Workshops
and join
the conversation.
TalkAboutHealth
Q&A
of the month
"Ablation
is a new procedure for the treatment of kidney cancer that has
even fewer complications than laparoscopic or robotic surgery and
also requires a much shorter recovery time. Until recently the
only treatment option for kidney tumors was to surgically remove
them, either by removing the entire kidney (radical nephrectomy)
or by removing just the tumor and surrounding region of kidney (partial
nephrectomy). More recently, new technologies allow tumors to be
destroyed, rendering them essentially harmless, without them
actually being removed. In one form of ablation, radiofrequency
energy is used to heat up and destroy the tumor. In another, known
as cryoablation, the tumors are frozen to very low temperatures
(-40 degrees Celsius!) and thereby destroyed. It is not clear
which patients are the best candidates for ablation. In general,
it seems the best candidates are patients with tumors less than
4cm in size. Also, there is a small risk that the patient will
require a second treatment, which must be considered as well.
Finally, the data on long-term outcomes are still being collected,
so patients who want the most “tried and true” methods might
opt for a different procedure"
(Answer by
Jaime
Landman, Department of Urology,University
of California, Irvine
,
CA, USA)
|
- 